Therapy of peripheral T/NK neoplasms.

Therapy of peripheral T/NK neoplasms.

Item
http://www.wikidata.org/entity/Q36662226
The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphomaA phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas.NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas.Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses.Natural killer cell neoplasms.State of the art in natural killer cell malignancies.DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma
P2860

Therapy of peripheral T/NK neoplasms.

Item
http://www.wikidata.org/entity/Q36662226
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Therapy of peripheral T/NK neoplasms.
@ast
Therapy of peripheral T/NK neoplasms.
@en
type
label
Therapy of peripheral T/NK neoplasms.
@ast
Therapy of peripheral T/NK neoplasms.
@en
prefLabel
Therapy of peripheral T/NK neoplasms.
@ast
Therapy of peripheral T/NK neoplasms.
@en
P1433
P1476
P2093
P304
P31
P356
P577
P5875
P698
P356
P1433
P1476
Therapy of peripheral T/NK neoplasms.
@en
P2093
P304
P31
P356
10.1182/ASHEDUCATION-2006.1.331
P577
P5875
P698